Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery

Significant weight loss can modify the progression of Nonalcoholic fatty liver disease (NAFLD) with the most convincing evidence coming from bariatric surgery cohorts. Effective ways to non-invasively characterise NAFLD in these patients has been lacking, with high Fibroscan failure rates reported....

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Andrew, Nguyen, Melinda, Ju, Irene, Brancatisano, Anthony, Ryan, Brendan, van der Poorten, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263818/
https://www.ncbi.nlm.nih.gov/pubmed/34234198
http://dx.doi.org/10.1038/s41598-021-93294-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263818/
https://www.ncbi.nlm.nih.gov/pubmed/34234198
http://dx.doi.org/10.1038/s41598-021-93294-6

Ejemplares similares